Summary of Changes
The T categories in this edition have been redefined and simplified.
All solitary tumors without vascular invasion, regardless of size, are classified as Tl because of similar prognosis.
All solitary tumors with vascular invasion (again regardless of size) are combined with multiple tumors ≤ 5 cm and classified as T2 because of similar prognosis.
Multiple tumors > 5 cm and tumors with evidence of major vascular invasion are combined and classified as T3 because of similarly poor prognosis.
Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum are classified separately as T4.
The separate subcategory for multiple bilobar tumors has been eliminated because of a lack of distinct prognostic value.
T3 NO tumors and tumors with lymph node involvement are combined into Stage III because of similar prognosis.
Stage IV defines metastatic disease only. The subcategories IVA and IVB have been eliminated.
Preview
Unable to display preview. Download preview PDF.
Bibliography
Bilimoria MM, Lauwers GY, Nagorney DM, et al: Underlying liver disease but not tumor factors predict long-term survival after hepatic resection of hepatocellular carcinoma. Arch Surg 136:528–535, 2001
Cance WG, Stewart AK, Menck HR: The National Cancer Data Base report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985–1996. Cancer 88:912–920, 2000
The Cancer of the Liver Italian Program (CLIP) investigators: Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31:840–845, 2000
Cantlie J: On a new arrangement of the right and left lobes of the liver. J Anat Physiol 32:iv–ix, 1897
Couinaud C: Basic knowledge of interest: the paracaval segments of the liver. J Hep Bil Pancr Surg 2:145–151, 1994
Edmondson HA, Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503, 1954
El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745–750, 1999
Fong Y, Sun RL, Larnagin W, et al: An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 229:790–800, 1998
Ikai I, Yamaoka Y, Yamamoto Y, et al: Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 227:433–439, 1998
Ishak K, Baptista A, Bianchi L, et al: Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699, 1995
Izumi R, Shimizu K, Ii T, Yagi M, et al: Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106:720–727, 1994
Jeng KS, Chen BF, Lin HJ: En bloc resection for extensive hepatocellular carcinoma: is it advisable? World J Surg 18:834–839, 1994
Kosuge T, Makuuchi M, Takayama T, et al: Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 40:328–332, 1993
Lau WY, Leung KL, Leung TW, et al: Resection of hepatocellular carcinoma with diaphragmatic invasion. Br J Surg 82:264–266, 1995
Lauwers GY, Vauthey IN: Pathological aspects of hepatocellular carcinoma: a critical review of prognostic factors. Hepatogastroenterology 45 (Suppl 3):1197–1202, 1998
Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338, 1999
Nzeako UC, Goodman ZD, Ishak KG: Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 105:65–75, 1996
Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928, 1985
Poon RT, Fan ST, Ng IO, et al: Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg 231:544–551, 2000
Pugh RN, Murray-Lyon IM, Dawson IL, et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649, 1973
Satoh, S, Ikai, I, Honda, G, et al: Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. Surgery 128:779–783, 2000
Staudacher C, Chiappa A, Biella F, et al: Validation of the modified TNM-Izumi classification for hepatocellular carcinoma. Tumori 86:8–11, 2000
Tsai TJ, Chau GY, Lui WY, et al: Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127:603–608, 2000
Tung WY, Chau GY, Loong CC, et al: Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). Eur J Surg Oncol 22:516–520, 1996
Vauthey IN, Klimstra D, Franceschi D, et al: Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am I Surg 169:28–35, 1995
Vauthey JN, Lauwers GY, Esnaola N, et al: A simplified staging for hepatocellular carcinoma. J Clin Oncol (in press)
Weimann A, Varnholt H, Schlitt HJ, et al: Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg 87:1182–1187, 2000
Wu CC, Ho WL, Lin MC, et al: Hepatic resection for bilobar multicentric hepatocellular carcinoma: is it justified? Surgery 123:270–277, 1998
Zhu LX, Wang GS, Fan, ST: Spontaneous rupture of hepatocellular carcinoma. Br J Surg 83:602–607, 2000
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
American Joint Committee on Cancer. (2002). Liver (Including Intrahepatic Bile Ducts). In: Greene, F.L., et al. AJCC Cancer Staging Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3656-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3656-4_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-3-540-00595-7
Online ISBN: 978-1-4757-3656-4
eBook Packages: Springer Book Archive